Development Programs

Proniras is on a mission to transform the landscape for the treatment of substance use and specialty central nervous system (CNS) disorders. As a nimble clinical stage company, our driving force is the relentless pursuit of innovative therapies that bring about positive change in the lives of individuals worldwide.

Our pipeline and clinical trials, explores novel interventions to address opioid withdrawal, alcohol withdrawal, neonatal abstinence, and epilepsy, as well as nerve agent countermeasure applications. We aim to translate early-stage science into transformative breakthroughs that redefine the experiences of those seeking relief from these challenging conditions.